Back to all Programs

Past Event

Related Materials

Past Event

International Workshop on HBV Cure 2022

Viral Hepatitis and Liver Disease

Therapy Induced Flares Associated With HBsAg Decline - Man-Fung Yuen

Viral Hepatitis and Liver Disease

Development of Assembly Next Generation Core Inhibitors - Grace Wang

Viral Hepatitis and Liver Disease

Evidence of T Cell Restoration after siRNA Therapy - Emily Thi

Viral Hepatitis and Liver Disease

How HBV RNA and HBcrAg Relate to cccDNA Transcriptional Activity - Barbara Testoni

Viral Hepatitis and Liver Disease

HBV-Specific T Cell Profile Associated with Functional Cure - Georg Lauer

Viral Hepatitis and Liver Disease

Why We Should Be Careful Using NA Withdrawal as a Therapeutic Option - Pietro Lampertico

Viral Hepatitis and Liver Disease

Bulevirtide - Data from Real World Usage after Approval in Europe - John Flaherty

Viral Hepatitis and Liver Disease

Is Therapy-Induced HBs Decline the Same as Naturally Low HBs? - Jordan Feld

Viral Hepatitis and Liver Disease

Toxicity Profiles of Checkpoint Inhibition, What to Expect and When to Be Concerned - M. Cunningham

Viral Hepatitis and Liver Disease

Cam-N Jnj-6379. Lessons Learned From Reef-1 and -2 Studies - Michael Biermer

Viral Hepatitis and Liver Disease

What to Watch Preclinical Therapeutics with Novel Mechanisms of Action - Massimo Levrero

Viral Hepatitis and Liver Disease

New Therapeutic Combination Trials – What Are Their Potential to Achieve a Cure? - Mark Sulkowski